BioTime names Angus Russell to board
This article was originally published in Scrip
BioTime, a biotechnology company that develops and markets products in the field of regenerative medicine, has named Angus C Russell, former CEO of Shire to its board of directors. Mr Russell retired from Shire in April 2013. BioTime's focus is on pluripotent stem cell technology based on human embryonic stem cells and induced pluripotent stem cells.